193
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Primary Drug-Resistance Pattern and Trend in Elderly Tuberculosis Patients in Shandong, China, from 2004 to 2019

, , , , , , , ORCID Icon, , , & show all
Pages 4133-4145 | Published online: 13 Nov 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Liang Du, Yu Zhang, Xintong Lv, Yuxin Duan, Xiaoyan Shi, Haoqiang Ji, Ruiheng Wu, Jia Xu, Xu Chen, Yang Gao, Xiwei Lu & Ling Zhou. (2021) Prevalence of Multidrug-Resistant Tuberculosis in Dalian, China: A Retrospective Study. Infection and Drug Resistance 14, pages 1037-1047.
Read now

Articles from other publishers (10)

Zhenzhen Wang, Yi Hou, Tengfei Guo, Tao Jiang, Liang Xu, Hongxia Hu, Zhanqin Zhao & Yun Xue. (2023) Epidemiological characteristics and risk factors of multidrug-resistant tuberculosis in Luoyang, China. Frontiers in Public Health 11.
Crossref
Huizheng Zhang, Ke Zhang, Xin Yang, Ming Luo, Chunhua Li, Xiaoying Wang & Kui Hu. (2022) Characteristics and Trend of Drug-Resistant Tuberculosis at a Major Specialized Hospital in Chongqing, China: 2016 Versus 2019. Disaster Medicine and Public Health Preparedness 17.
Crossref
Zhenzhen Wang, Tengfei Guo, Tao Jiang, Zhanqin Zhao, Xiangyang Zu, Long li, Qing Zhang, Yi Hou, Kena Song & Yun Xue. (2022) Regional distribution of Mycobacterium tuberculosis infection and resistance to rifampicin and isoniazid as determined by high-resolution melt analysis. BMC Infectious Diseases 22:1.
Crossref
Javier Suárez-González, Amor R. Cáceres-Pérez, Alexis Oliva, Ana Santoveña-Estévez & José B. Fariña. (2022) Development and Optimization of a New UPLC-UV/MS Method through DoE and MLR for Detecting Substandard Drug Products to Treat Tuberculosis. Molecules 27:20, pages 7141.
Crossref
Juliet Addo, Dave Pearce, Marilyn Metcalf, Courtney Lundquist, Gillian Thomas, David Barros-Aguirre, Gavin C. K. W. Koh & Mike Strange. (2022) Living with tuberculosis: a qualitative study of patients’ experiences with disease and treatment. BMC Public Health 22:1.
Crossref
Xiaoling Zhang & Jingyu Chi. (2022) Clinical Study of Different Treatment Methods for Tuberculous Pleuritis Complicated with Pleural Tuberculoma. Computational and Mathematical Methods in Medicine 2022, pages 1-9.
Crossref
K.K. Chopra, S. Matta & V.K. Arora. (2022) Drug resistant tuberculosis among elderly: Challenges. Indian Journal of Tuberculosis 69, pages S202-S204.
Crossref
Avdhesh Bansal & Shweta Arora. (2022) MDR tuberculosis in elderly. Indian Journal of Tuberculosis 69, pages S267-S271.
Crossref
Ling Chen, Xuefeng Fu, Peng Tian, Qing Li, Dan Lei, Zhangli Peng, Quanxian Liu, Nana Li, Jianyong Zhang, Peng Xu & Hong Zhang. (2021) Upward trends in new, rifampicin-resistant and concurrent extrapulmonary tuberculosis cases in northern Guizhou Province of China. Scientific Reports 11:1.
Crossref
Fuminori Mizukoshi, Nobuyuki Kobayashi, Fumiko Kirikae, Ken Ohta, Kazunari Tsuyuguchi, Noritaka Yamada, Yoshikazu Inoue, Masahide Horiba, Noriko Kawata, Akiko Ichinose, Tohru Miyoshi-Akiyama, Reiko Kiritani, Keiji Funatogawa & Teruo Kirikae. (2021) Molecular Epidemiology of Drug-Resistant Mycobacterium Tuberculosis in Japan. mSphere 6:4.
Crossref